Sandborn, William J <br/><br/>
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial.  [electronic resource] 

 -  Gastroenterology  Jan 2016 
 - 96-102 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2015.09.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Area Under Curve<br/>Biomarkers--analysis<br/>Colitis, Ulcerative--diagnosis<br/>Colonoscopy--methods<br/>Confidence Intervals<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Feces--chemistry<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Leukocyte L1 Antigen Complex--metabolism<br/>Male<br/>Middle Aged<br/>Piperidines--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Pyrroles--therapeutic use<br/>ROC Curve<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Young Adult